Document is current

Article History

Received: 3 April 2020

Accepted: 8 June 2020

First Online: 30 June 2020

Ethics approval and consent to participate {24}

: This study was approved by the Ethics Committee of Ulm University on August 28, 2019 (application number: 259/19) and by local ethics committees (Landesärztekammer Bayern, Landesärztekammer des Saarlandes, Landesärztekammer Berlin, Landesärztekammer Sachsen, Landesärztekammer Nordrhein, Landesärztekammer Westfalen-Lippe). All of the participants will be asked to give written informed consent if they agree to participate in this study. The informed consent form describes the objective of the study and the study procedures for participants and explains what a randomised, controlled trial is. Moreover, details are given on pseudonymisation, voluntariness, risks, insurances, confidentiality, and study allowances in this study. Special attention is paid to data management, data storage, and data protection. Contact data of the research institution, service providers, and health insurances and their data protection officers are given. Informed consent forms in German are available on request from the corresponding author.

: Not applicable.

: All of the authors declare that they have no competing interests.The project is funded by the Innovation Fund from the Federal Joint Committee (G-BA), grant number 01NVF18028 (GBV). The Federal Joint Committee (G-BA) is the highest decision-making body of the joint self-government of physicians, dentists, hospitals, and health insurance funds in Germany.The funding body had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.